Structural Heart Disease

Structural heart diseases include any issues preventing normal cardiovascular function due to damage or alteration to the anatomical components of the heart. This is caused by aging, advanced atherosclerosis, calcification, tissue degeneration, congenital heart defects and heart failure. The most commonly treated areas are the heart valves, in particular the mitral and aortic valves. These can be replaced through open heart surgery or using cath lab-based transcatheter valves or repairs to eliminate regurgitation due to faulty valve leaflets. This includes transcatheter aortic valve replacement (TAVR). Other common procedures include left atrial appendage (LAA) occlusion and closing congenital holes in the heart, such as PFO and ASD. A growing area includes transcatheter mitral repair or replacement and transcatheter tricuspid valve repair and replacement.

Benefit of restrictive transfusions with coronary surgery put in doubt

Secondary analysis of data from the TITRe2 trial found restrictive transfusion thresholds following cardiac surgery not superior to liberal thresholds when evaluating morbidity and cost at three months.

Thumbnail

Breathing Easy Using Extubation in the OR

Many cardiac surgery programs support early extubation of suitable CABG patients once they enter intensive care, based on clinical and economic benefits. Now some hospitals have shifted extubation to the cardiac operating room (OR) for a wide range of patients, young and old, with good results.

Thumbnail

TAVR death rate rises to 23.7 percent at 1 year in registry analysis

Updating a prior report on 30-day transcatheter aortic valve replacement (TAVR) outcomes of Medicare patients, researchers found several characteristics significantly associated with one-year mortality, according to an article published March 10 in JAMA.

Thumbnail

An ACC highlight & why it matters

Here is what I am looking forward to at the American College of Cardiology’s confab next weekend—besides warm weather and sunshine.

Thumbnail

Quality measure may cause unintended harms

Physicians have begun to question the value of 30-day mortality as a measure of quality, saying that it may sway decisions to treat or not to treat high-risk cardiac surgery and MI patients, the New York Times reports.

Thumbnail

Robots lend a hand to success in cardiac operating rooms

Robotic technology is allowing cardiac surgeons to perform delicate surgery that is less invasive and minimizes risk, the Mayo Clinic News Network reported.

Thumbnail

Cholesterol takes back seat to whole diet in USDA recommendations

It’s all about the whole diet, say experts in a draft of scientific findings on the U.S. Food and Drug Administration (USDA) website. The results, published for comment through April 8, offer diets for physicians to consider with their patients when working to improve cardiovascular risks, heart disease, obesity, and other health concerns.

Hypertension guideline writing process underway; new recommendations for managing high blood pressure expected in 2016

A multi-disciplinary writing panel led by the American College of Cardiology and the American Heart Association has begun work on a new guideline for the management of hypertension to update 12-year-old recommendations.  Nine additional medical societies have signed on as partners in the effort.

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.